Cargando…
What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes
CONTEXT: The primary lesion in penile cancer is managed by surgery or radiation. Surgical options include penile-sparing surgery, amputative surgery, laser excision, and Moh’s micrographic surgery. Radiation is applied as external beam radiotherapy (EBRT) and brachytherapy. The treatment aims to com...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079254/ https://www.ncbi.nlm.nih.gov/pubmed/35540709 http://dx.doi.org/10.1016/j.euros.2022.04.002 |
_version_ | 1784702522466762752 |
---|---|
author | Sakalis, Vasileios I. Campi, Riccardo Barreto, Lenka Perdomo, Herney Garcia Greco, Isabella Zapala, Łukasz Kailavasan, Mithun Antunes-Lopes, Tiago Marcus, Jack David Manzie, Kenneth Osborne, John Ayres, Benjamin Moonen, Luc M.F. Necchi, Andrea Crook, Juanita Oliveira, Pedro Pagliaro, Lance C. Protzel, Chris Parnham, Arie S. Albersen, Maarten Pettaway, Curtis A. Spiess, Philippe E. Tagawa, Scott T. Rumble, R. Bryan Brouwer, Oscar R. |
author_facet | Sakalis, Vasileios I. Campi, Riccardo Barreto, Lenka Perdomo, Herney Garcia Greco, Isabella Zapala, Łukasz Kailavasan, Mithun Antunes-Lopes, Tiago Marcus, Jack David Manzie, Kenneth Osborne, John Ayres, Benjamin Moonen, Luc M.F. Necchi, Andrea Crook, Juanita Oliveira, Pedro Pagliaro, Lance C. Protzel, Chris Parnham, Arie S. Albersen, Maarten Pettaway, Curtis A. Spiess, Philippe E. Tagawa, Scott T. Rumble, R. Bryan Brouwer, Oscar R. |
author_sort | Sakalis, Vasileios I. |
collection | PubMed |
description | CONTEXT: The primary lesion in penile cancer is managed by surgery or radiation. Surgical options include penile-sparing surgery, amputative surgery, laser excision, and Moh’s micrographic surgery. Radiation is applied as external beam radiotherapy (EBRT) and brachytherapy. The treatment aims to completely remove the primary lesion and preserve a sufficient functional penile stump. OBJECTIVE: To assess whether the 5-yr recurrence-free rate and other outcomes, such as sexual function, quality of life, urination, and penile preserving length, vary between various treatment options. EVIDENCE ACQUISITION: The EMBASE, MEDLINE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials (CENTRAL; Cochrane HTA, DARE, HEED), Google Scholar, and ClinicalTrials.gov were searched for publications from 1990 through May 2021. Randomized controlled trials, nonrandomized comparative studies (NRCSs), and case series (CSs) were included. EVIDENCE SYNTHESIS: The systematic review included 88 studies, involving 9578 men from 16 NRCSs and 72 CSs. The cumulative mean 5-yr recurrence-free rates were 82.0% for penile-sparing surgery, 83.9% for amputative surgery, 78.6% for brachytherapy, 55.2% for EBRT, 69.4% for lasers, and 88.2% for Moh’s micrographic surgery, as reported from CSs, and 76.7% for penile-sparing surgery and 93.3% for amputative surgery, as reported from NRCSs. Penile surgery affects sexual function, but amputative surgery causes more appearance concerns. After brachytherapy, 25% of patients reported sexual dysfunction. Both penile-sparing surgery and amputative surgery affect all aspects of psychosocial well-being. CONCLUSIONS: Despite the poor quality of evidence, data suggest that penile-sparing surgery is not inferior to amputative surgery in terms of recurrence rates in selected patients. Based on the available information, however, broadly applicable recommendations cannot be made; appropriate patient selection accounts for the relative success of all the available methods. PATIENT SUMMARY: We reviewed the evidence of various techniques to treat penile tumor and assessed their effectiveness in oncologic control and their functional outcomes. Penile-sparing as well as amputative surgery is an effective treatment option, but amputative surgery has a negative impact on sexual function. Penile-sparing surgery and radiotherapy are associated with a higher risk of local recurrence, but preserve sexual function and quality of life better. Laser and Moh’s micrographic surgery could be used for smaller lesions. |
format | Online Article Text |
id | pubmed-9079254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90792542022-05-09 What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes Sakalis, Vasileios I. Campi, Riccardo Barreto, Lenka Perdomo, Herney Garcia Greco, Isabella Zapala, Łukasz Kailavasan, Mithun Antunes-Lopes, Tiago Marcus, Jack David Manzie, Kenneth Osborne, John Ayres, Benjamin Moonen, Luc M.F. Necchi, Andrea Crook, Juanita Oliveira, Pedro Pagliaro, Lance C. Protzel, Chris Parnham, Arie S. Albersen, Maarten Pettaway, Curtis A. Spiess, Philippe E. Tagawa, Scott T. Rumble, R. Bryan Brouwer, Oscar R. Eur Urol Open Sci Review – Penile Cancer CONTEXT: The primary lesion in penile cancer is managed by surgery or radiation. Surgical options include penile-sparing surgery, amputative surgery, laser excision, and Moh’s micrographic surgery. Radiation is applied as external beam radiotherapy (EBRT) and brachytherapy. The treatment aims to completely remove the primary lesion and preserve a sufficient functional penile stump. OBJECTIVE: To assess whether the 5-yr recurrence-free rate and other outcomes, such as sexual function, quality of life, urination, and penile preserving length, vary between various treatment options. EVIDENCE ACQUISITION: The EMBASE, MEDLINE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials (CENTRAL; Cochrane HTA, DARE, HEED), Google Scholar, and ClinicalTrials.gov were searched for publications from 1990 through May 2021. Randomized controlled trials, nonrandomized comparative studies (NRCSs), and case series (CSs) were included. EVIDENCE SYNTHESIS: The systematic review included 88 studies, involving 9578 men from 16 NRCSs and 72 CSs. The cumulative mean 5-yr recurrence-free rates were 82.0% for penile-sparing surgery, 83.9% for amputative surgery, 78.6% for brachytherapy, 55.2% for EBRT, 69.4% for lasers, and 88.2% for Moh’s micrographic surgery, as reported from CSs, and 76.7% for penile-sparing surgery and 93.3% for amputative surgery, as reported from NRCSs. Penile surgery affects sexual function, but amputative surgery causes more appearance concerns. After brachytherapy, 25% of patients reported sexual dysfunction. Both penile-sparing surgery and amputative surgery affect all aspects of psychosocial well-being. CONCLUSIONS: Despite the poor quality of evidence, data suggest that penile-sparing surgery is not inferior to amputative surgery in terms of recurrence rates in selected patients. Based on the available information, however, broadly applicable recommendations cannot be made; appropriate patient selection accounts for the relative success of all the available methods. PATIENT SUMMARY: We reviewed the evidence of various techniques to treat penile tumor and assessed their effectiveness in oncologic control and their functional outcomes. Penile-sparing as well as amputative surgery is an effective treatment option, but amputative surgery has a negative impact on sexual function. Penile-sparing surgery and radiotherapy are associated with a higher risk of local recurrence, but preserve sexual function and quality of life better. Laser and Moh’s micrographic surgery could be used for smaller lesions. Elsevier 2022-05-02 /pmc/articles/PMC9079254/ /pubmed/35540709 http://dx.doi.org/10.1016/j.euros.2022.04.002 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review – Penile Cancer Sakalis, Vasileios I. Campi, Riccardo Barreto, Lenka Perdomo, Herney Garcia Greco, Isabella Zapala, Łukasz Kailavasan, Mithun Antunes-Lopes, Tiago Marcus, Jack David Manzie, Kenneth Osborne, John Ayres, Benjamin Moonen, Luc M.F. Necchi, Andrea Crook, Juanita Oliveira, Pedro Pagliaro, Lance C. Protzel, Chris Parnham, Arie S. Albersen, Maarten Pettaway, Curtis A. Spiess, Philippe E. Tagawa, Scott T. Rumble, R. Bryan Brouwer, Oscar R. What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes |
title | What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes |
title_full | What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes |
title_fullStr | What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes |
title_full_unstemmed | What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes |
title_short | What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes |
title_sort | what is the most effective management of the primary tumor in men with invasive penile cancer: a systematic review of the available treatment options and their outcomes |
topic | Review – Penile Cancer |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079254/ https://www.ncbi.nlm.nih.gov/pubmed/35540709 http://dx.doi.org/10.1016/j.euros.2022.04.002 |
work_keys_str_mv | AT sakalisvasileiosi whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT campiriccardo whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT barretolenka whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT perdomoherneygarcia whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT grecoisabella whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT zapalałukasz whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT kailavasanmithun whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT antuneslopestiago whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT marcusjackdavid whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT manziekenneth whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT osbornejohn whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT ayresbenjamin whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT moonenlucmf whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT necchiandrea whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT crookjuanita whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT oliveirapedro whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT pagliarolancec whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT protzelchris whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT parnhamaries whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT albersenmaarten whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT pettawaycurtisa whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT spiessphilippee whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT tagawascottt whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT rumblerbryan whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes AT brouweroscarr whatisthemosteffectivemanagementoftheprimarytumorinmenwithinvasivepenilecancerasystematicreviewoftheavailabletreatmentoptionsandtheiroutcomes |